Ocular Therapeutix (OCUL) Accumulated Depreciation & Amortization: 2013-2024
- Ocular Therapeutix's Accumulated Depreciation & Amortization rose 16.64% to $23.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $76.4 million, marking a year-over-year increase of 16.55%. This contributed to the annual value of $23.6 million for FY2024, which is 16.64% up from last year.
- According to the latest figures from Q4 2024, Ocular Therapeutix's Accumulated Depreciation & Amortization is $23.6 million, which was up 16.64% from $20.3 million recorded in Q4 2023.
- In the past 5 years, Ocular Therapeutix's Accumulated Depreciation & Amortization registered a high of $23.6 million during Q4 2024, and its lowest value of $12.8 million during Q4 2020.
- Over the past 3 years, Ocular Therapeutix's median Accumulated Depreciation & Amortization value was $20.3 million (recorded in 2023), while the average stood at $20.4 million.
- Data for Ocular Therapeutix's Accumulated Depreciation & Amortization shows a peak YoY rose of 27.62% (in 2020) over the last 5 years.
- Over the past 5 years, Ocular Therapeutix's Accumulated Depreciation & Amortization (Quarterly) stood at $12.8 million in 2020, then increased by 18.93% to $15.2 million in 2021, then increased by 13.62% to $17.3 million in 2022, then grew by 17.26% to $20.3 million in 2023, then increased by 16.64% to $23.6 million in 2024.
- Its Accumulated Depreciation & Amortization stands at $23.6 million for Q4 2024, versus $20.3 million for Q4 2023 and $17.3 million for Q4 2022.
